Approval · Notice of Compliance 6319 · 1999
IMITREX: Notice of Compliance 6319
Issued March 2, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6319
- Date
- March 2, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength, revised dosage regimen
- Therapeutic class
- 5-ht1 receptor agonist, migraine therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMITREX | 02239738 | Cancelled Post Market |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 25 MG per TAB